Publicaciones en colaboración con investigadores/as de AstraZeneca (United Kingdom) (20)

2024

  1. Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or Ovarian Cancer

    JAMA network open, Vol. 7, Núm. 4, pp. e247811

2023

  1. Clinical burden related to oral corticosteroid treatment of severe asthma in Spain: LEVANTE study

    Journal of Asthma, Vol. 60, Núm. 5, pp. 890-899

  2. Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 9, pp. 2803-2811

2022

  1. The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study

    Respiratory Medicine, Vol. 200

2021

  1. Real-world study in severe eosinophilic asthma patients refractory to anti-IL5 biological agents treated with benralizumab in Spain (ORBE study)

    BMC Pulmonary Medicine, Vol. 21, Núm. 1

2018

  1. Characteristics of COPD Patients Managed in Respiratory Medicine Departments in Spain, According to GOLD Groups and GesEPOC Clinical Phenotypes

    Archivos de Bronconeumologia, Vol. 54, Núm. 11, pp. 559-567

  2. Comparison of plasma ctDNA and tissue/cytology-based techniques for the detection of EGFR mutation status in advanced NSCLC: Spanish data subset from ASSESS

    Clinical and Translational Oncology, Vol. 20, Núm. 10, pp. 1261-1267

  3. Creation of the SAQ-COPD Questionnaire to Determine Physical Activity in COPD Patients in Clinical Practice

    Archivos de Bronconeumologia, Vol. 54, Núm. 9, pp. 467-475

2017

  1. Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial

    Arthritis and Rheumatology, Vol. 69, Núm. 9, pp. 1903-1913

  2. The variability of respiratory symptoms and associated factors in COPD

    Respiratory Medicine, Vol. 129, pp. 165-172

2016

  1. 147P: Level of concordance between EGFR mutation status obtained from tissue/cytology and blood (plasma) for advanced non-small-cell lung cancer in Spain: ASSESS study

    Journal of Thoracic Oncology, Vol. 11, Núm. 4, pp. S122

  2. Computational Lexical Analysis of the Language Commonly Used to Describe Gout

    Arthritis Care and Research, Vol. 68, Núm. 6, pp. 763-768

2014

  1. Erratum to The Phosphatidyl-myo-Inositol Mannosyltransferase PimA Is Essential for Mycobacterium tuberculosis Growth In Vitro and In Vivo [Journal of Bacteriology, 196, 19, (2014) 3441-3451] DOI: 10.1128/JB.02332-14

    Journal of Bacteriology

  2. The phosphatidyl-myo-inositol mannosyltransferase PimA is essential for Mycobacterium tuberculosis growth in vitro and in vivo

    Journal of Bacteriology, Vol. 196, Núm. 19, pp. 3441-3451

2012

  1. Validación de la versión en castellano de la Escala del Bienestar Subjetivo con Neurolépticos (SWN-K) en pacientes con esquizofrenia

    Medicina Clinica, Vol. 138, Núm. 4, pp. 151-154

  2. Vandetanib with docetaxel as second-line treatment for advanced breast cancer: A double-blind, placebo-controlled, randomized Phase II study

    Investigational New Drugs, Vol. 30, Núm. 2, pp. 681-687

2010

  1. Bases neurobiológicas del efecto antidepresivo de la quetiapina en el trastorno bipolar

    Actas Espanolas de Psiquiatria, Vol. 38, Núm. 1, pp. 22-32

2008

  1. Validity and reliability of the Spanish versions of the Bech-Rafaelsen's mania and melancholia scales for bipolar disorders

    Acta Psychiatrica Scandinavica, Vol. 117, Núm. 3, pp. 207-215

2007

  1. Sensitivity to change, discriminative performance, and cutoff criteria to define remission for embedded short scales of the Hamilton depression rating scale (HAMD)

    Journal of Affective Disorders, Vol. 102, Núm. 1-3, pp. 93-99

  2. The sufficiency of the HAM-D6 as an outcome instrument in the acute therapy of antidepressants in the outpatient setting

    International Journal of Psychiatry in Clinical Practice, Vol. 11, Núm. 2, pp. 146-150